Oxytocin receptor: Expression in the trigeminal nociceptive system and potential role in the treatment of headache disorders

Alexander Tzabazis, Jordan Mechanic, James Miller, +11

Cephalalgia

Nociceptive sensitization and BDNF up-regulation in a rat model of traumatic brain injury

David P. Feliciano, Peyman Sahbaie, Xiaoyou Shi, +3

Neuroscience Letters

Traumatic Brain InjuryPain MedicineNeuropathic PainMolecular PainRat Model +15

Visualizing Nerve Injury in a Neuropathic Pain Model with [¹⁸F]FTC-146 PET/MRI

Bin Shen, Deepak Behera, Michelle L. James, +13

Theranostics

Single intrathecal administration of the transcription factor decoy AYX1 prevents acute and chronic pain after incisional, inflammatory, or neuropathic injury

Julien Mamet, Michael Klukinov, Tony L. Yaksh, +13

Pain

Pain TherapyPain DisordersTranscription Factor Egr1Acute PainKnee Surgery Model +21

Selective Nociceptor Activation in Volunteers by Infrared Diode Laser

Alexander Tzabazis, Michael Klukinov, Sonia Crottaz‐Herbette, +3

Molecular Pain

Intranasal Oxytocin Attenuates Reactive and Ongoing, Chronic Pain in a Model of Mild Traumatic Brain Injury

Anders Christian Meidahl, Andreas Eisenried, Michael Klukinov, +3

Headache The Journal of Head and Face Pain

Gene therapy for trigeminal pain in mice

Alexander Tzabazis, Michael Klukinov, David P. Feliciano, +2

Gene Therapy

Gene TherapiesHealth SciencesPain MedicineMedicineNeuropathic Pain +5

Nasal application of HSV encoding human preproenkephalin blocks craniofacial pain in a rat model of traumatic brain injury

Anders Christian Meidahl, Michael Klukinov, Alexander Tzabazis, +1

Gene Therapy

Impact of Magnesium on Oxytocin Receptor Function

Vimala N. Bharadwaj, Justin Meyerowitz, Bende Zou, +6

Pharmaceutics

Nervous system delivery of antilysophosphatidic acid antibody by nasal application attenuates mechanical allodynia after traumatic brain injury in rats

Andreas Eisenried, Anders Christian Meidahl, Michael Klukinov, +4

Pain

Traumatic Brain InjuryImmune RegulationImmunologyImmunotherapyAnti-lpa Mab +28